norovirus

July 16, 2021

Study identifies monoclonal antibodies that may neutralize many norovirus variants

Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.

By Bill Snyder

August 6, 2020

ID of ‘stomach flu’ culprit

Identifying the norovirus genotypes associated with more severe infections in children could guide strain selection for candidate norovirus vaccines.

By Leigh MacMillan

August 30, 2018

Team isolates antibodies that neutralize GI bug norovirus

Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies that can neutralize norovirus, the leading cause of acute gastrointestinal illness in the world.

By Bill Snyder

September 28, 2016

Targeting norovirus “noxiousness”

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea.

By Bill Snyder

July 1, 2016

Swimmers beware: fecal contamination a concern in hot weather

By Wayne Wood

March 28, 2013

Surveillance network tracks shift in cause of childhood diarrhea

A national vaccine surveillance program that Vanderbilt University is a part of has identified a significant shift in the most common cause of childhood diarrhea.

By VUMC News and Communications